Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | 1,1'-Carbonyldiimidazole | HCID 68263 | — |
| Reactant | N-(tert-butoxycarbonyl)glycine | HCID 78288 | — |
| Reactant | HCID 54277862 | HCID 54277862 | — |
| Product | HCID 70076785 | HCID 70076785 | 89% |
Reaction Steps
36.4 g (205 mmol) of BOC-glycine were dissolved in 300 ml of N,N-dimethylformamide and treated portionwise with 35.8 g (220 mmol) of 1,1'-carbonyldiimidazole. The solution was stirred at 50° for 30 minutes, 54.7 g (194 mmol) of (S)-9-oxo-12,12a-dihydro-9H,11H-azeto[2,1- c]imidazo[1,5-a][1,4]benzodiazepine-1-carboxamidoxime were added thereto and the mixture was stirred at 90° overnight. After evaporating the solvent the residue was dissolved in methylene chloride and the solution was washed with water, dried over magnesium sulfate and concentrated. By chromatography of the residue on silica gel while eluting with ethyl acetate there were obtained 73 g (89%) of (S)-1-(5-BOC-aminomethyl-1,2,4-oxadiazol-3-yl)-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one as a white foam, which was used in the next step without further purification.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05665718 |
|---|
| Source dataset | uspto-grants-1997_09 |
|---|
| ORD ID | ord-901728231b74489ba94cb82b0d0651da |
|---|
| Source note | uspto-grants-1997_09 |
|---|